Literature DB >> 12447704

Definition and classification of autoimmune hepatitis.

Ian G McFarlane1.   

Abstract

Autoimmune hepatitis (AIH) has been defined as "an unresolving, predominantly periportal hepatitis, usually with hypergammaglobulinemia and tissue autoantibodies, which is responsive to immunosuppressive therapy in most cases." It is a relatively rare disorder, with a preponderance of female patients, that can present at any age (although onset in most cases is after 40 years of age). There are no features that are pathognomonic of the condition. Diagnosis requires careful exclusion of other causes of liver disease together with the finding of a suggestive pattern of clinical and laboratory abnormalities. The marked heterogeneity of AIH with respect to presenting features, severity of disease, and response to therapy has led to several proposals for classification of the disease according to (mainly) immunologic parameters. These schemata may assist in diagnosis, and some may define different pathogenetic subgroups of the disease, but their utility for assessing prognosis or planning treatment strategies for the individual patient is still uncertain.

Entities:  

Mesh:

Year:  2002        PMID: 12447704     DOI: 10.1055/s-2002-35702

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  12 in total

1.  Vaccination-induced autoimmune hepatitis.

Authors:  Ganesh R Veerappan; Brian P Mulhall; Kent C Holtzmuller
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population.

Authors:  Navchetan Kaur; Ranjana W Minz; Shashi Anand; Biman Saikia; Ritu Aggarwal; Ashim Das; Babu R Thapa; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2013-12-16

3.  Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis.

Authors:  Heiko Mix; Christina Weiler-Normann; Robert Thimme; Golo Ahlenstiel; Eui-Cheol Shin; Johannes Herkel; Chella S David; Ansgar W Lohse; Barbara Rehermann
Journal:  Gastroenterology       Date:  2008-07-31       Impact factor: 22.682

4.  Chronic elevation of liver enzymes in acute intermittent porphyria initially misdiagnosed as autoimmune hepatitis.

Authors:  A González Estrada; S García-Morillo; L Gómez Morales; P Stiefel García-Junco
Journal:  Int J Hepatol       Date:  2011-01-18

5.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

Review 6.  Update on Autoimmune Hepatitis.

Authors:  Rodrigo Liberal; Diego Vergani; Giorgina Mieli-Vergani
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

7.  Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan.

Authors:  Nasir Hassan; Adeelur Rehman Siddiqui; Zaigham Abbas; Syed Mujahid Hassan; Ghous Bux Soomro; Muhammed Mubarak; Sabiha Anis; Rana Muzaffar; Mirza Naqi Zafar
Journal:  Hepat Mon       Date:  2013-12-16       Impact factor: 0.660

8.  Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Authors:  Bilger Çavuş; Filiz Akyuz; Raim İliaz; Alp Atasoy; Umit Akyuz; Kadir Demir; Fatih Besisik; Sabahattin Kaymakoglu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

9.  Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis: insights from an in silico study.

Authors:  Alessandro Paiardini; Stefano Pascarella
Journal:  Theor Biol Med Model       Date:  2013-04-10       Impact factor: 2.432

10.  Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population.

Authors:  Ayesha Zahiruddin; Abtin Farahmand; Paul Gaglio; Hatef Massoumi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.